The potential approval of Vertex’s IgAN therapy povetacicept in 2026 comes amid launch headwinds for the company’s non-opioid ...

Relatives urge PM to meet them, reassert commitment to bring back all 8 remaining bodies; Elad Or to ToI: 'If this deal ...

Globally, more than 600 million adults experience some form of back pain, making it the leading cause of disability, ...

Burning eyes are often caused by dryness, allergies, or environmental irritants, leading to discomfort and vision issues.

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA ...

One in seven people experience migraine’s disabling reach. Millions more, including me, endure other headache disorders. I ...

Carson Wentz has been placed on injured reserve and will undergo season-ending shoulder surgery, according to CBS Sports NFL ...

An NHS worker with a deadly cancer is trying to raise £120,000 for life-extending treatment. Jamie Scott has been told she ...

WHEN a kiss from Sarah Susak’s husband gave her what felt like an electric shock, she didn’t think much of it. But the ...

The FDA has approved Epioxa™ HD 0.239% and Epioxa™ 0.177% for use in epithelium-on corneal collagen CXL for the treatment of ...

A new eye drop, Vizz, was recently FDA approved and is helping people regain near vision without glasses. Originally used for ...

Glaucoma therapies have come a long way, but pain points still remain, according to a speaker at the American Academy of ...